Neuralink, Elon Musk's brain-computer interface company, aims to reach $1 billion in revenue by 2031. Recently valued at $9 billion after securing $650 million in funding, the company has achieved FDA clearance for human trials and successfully implanted its first device in a paralyzed patient. The global BCI market is expected to grow from $2.5 billion to $10.5 billion by 2031, with Neuralink targeting 20,000 annual procedures. Their strategy includes securing regulatory approvals, launching products for communication, vision restoration, and Parkinson's treatment, and expanding from medical applications to broader consumer uses as technology advances.